Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
51.94 USD | -0.81% | -0.79% | +31.75% |
08/05 | Earnings Flash (KROS) KEROS THERAPEUTICS Reports Q1 Revenue $83,000 | MT |
08/05 | Keros Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.75% | 1.89B | |
+9.42% | 115B | |
+13.07% | 107B | |
-13.45% | 22.31B | |
-3.49% | 21.6B | |
-5.29% | 18.23B | |
-38.57% | 17.62B | |
+7.56% | 14.26B | |
+34.66% | 12.37B | |
-26.67% | 8.28B |
- Stock Market
- Equities
- KROS Stock
- News Keros Therapeutics, Inc.
- Keros Therapeutics : HC Wainwright Adjusts Keros Therapeutics' Price Target to $100 From $50, Keeps at Buy